NCT06842407招募中不适用
Nuovi Bersagli Per lo Sviluppo di Anticorpi Monoclonali Per Immunoterapia - (Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)
Checkmab S.r.l.1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2023年4月1日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 600
- 试验地点
- 1
- 主要终点
- Validation of molecular targets for immunotherapy
研究概览
简要总结
The first objective of the project consists in the preclinical validation of new possible molecular targets associated with intratumoral T regulatory cells. The second objective consists in the selection of monoclonal antibodies with therapeutic potential, specific for the selected targets.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •blood donors
- •age of 18 years or more
- •able to sign informed consent
排除标准
- •age below 18 years
- •Positive for HIV, HCV, HBV
- •not suitable for blood donation
- •not able to understand or sign informed consent
结局指标
主要结局
Validation of molecular targets for immunotherapy
时间窗: 04.2023-06.2026
Selection of therapeutic antibodies
时间窗: 04.2023-06.2026
次要结局
- Set up of immunological assays to adress monoclonal antibodies mechanism of action(04.2023-06.2026)
研究者
研究点 (1)
Loading locations...
相似试验
撤回
2 期
A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerBreast CancerNCT04188119The Christie NHS Foundation Trust42
撤回
2 期
A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerBreast CancerNCT03794596The Christie NHS Foundation Trust
尚未招募
不适用
New Antigens Against GlioblastomaGlioblastoma MultiformeNCT05917821Fondazione Policlinico Universitario Agostino Gemelli IRCCS120
招募中
不适用
Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal TumorsKidney CancerNCT03571438University Hospital, Grenoble100
尚未招募
不适用
Towards the development of neo-antigen-targeted, personalized immunotherapies for advanced colorectal cancer patients.Colorectal carcinoma10017990Colorectal cancerNL-OMON42438eids Universitair Medisch Centrum50